These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32315375)

  • 1. Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy.
    Zhou Y; Chen X; Cao J; Gao H
    J Mater Chem B; 2020 Aug; 8(31):6765-6781. PubMed ID: 32315375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.
    Sun Y; Li Y; Shi S; Dong C
    Molecules; 2021 May; 26(9):. PubMed ID: 34062992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
    Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
    Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-sensitive drug-delivery systems for tumor targeting.
    He X; Li J; An S; Jiang C
    Ther Deliv; 2013 Dec; 4(12):1499-510. PubMed ID: 24304248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically based strategies for overcoming in vivo barriers with functional nano-delivery systems.
    Ahmadzadeh R; Taheri SA; Mohammadi N; Hjazi A; Menon SV; Kadhum WR; Kumar A; Shakir MN; Shayan FK; Shirinkami N
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23782. PubMed ID: 39115384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
    Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
    Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment.
    Fan X; Wang K; Lu Q; Lu Y; Liu F; Li L; Li S; Ye H; Zhao J; Cao L; Zhang H; He Z; Sun J
    Acta Biomater; 2022 Dec; 154():412-423. PubMed ID: 36280028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment.
    Ivey JW; Bonakdar M; Kanitkar A; Davalos RV; Verbridge SS
    Cancer Lett; 2016 Sep; 380(1):330-9. PubMed ID: 26724680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart Nanoparticles Undergo Phase Transition for Enhanced Cellular Uptake and Subsequent Intracellular Drug Release in a Tumor Microenvironment.
    Ye G; Jiang Y; Yang X; Hu H; Wang B; Sun L; Yang VC; Sun D; Gao W
    ACS Appl Mater Interfaces; 2018 Jan; 10(1):278-289. PubMed ID: 29260563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
    Sia CS; Lim HP; Tey BT; Goh BH; Low LE
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Intracellular and Extracellular Microenvironment of Tumor Site: The Trigger of Stimuli-Responsive Drug Delivery Systems.
    Jing X; Hu H; Sun Y; Yu B; Cong H; Shen Y
    Small Methods; 2022 Mar; 6(3):e2101437. PubMed ID: 35048560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supramolecular nanomotors with "pH taxis" for active drug delivery in the tumor microenvironment.
    Mathesh M; Sun J; van der Sandt F; Wilson DA
    Nanoscale; 2020 Nov; 12(44):22495-22501. PubMed ID: 33169767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acidity-Triggered Ligand-Presenting Nanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors.
    Wang T; Wang D; Liu J; Feng B; Zhou F; Zhang H; Zhou L; Yin Q; Zhang Z; Cao Z; Yu H; Li Y
    Nano Lett; 2017 Sep; 17(9):5429-5436. PubMed ID: 28753017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration.
    Cun X; Li M; Wang S; Wang Y; Wang J; Lu Z; Yang R; Tang X; Zhang Z; He Q
    Nanoscale; 2018 May; 10(21):9935-9948. PubMed ID: 29770822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.